
Mark Damante, MD
@markd_jr
PGY-4 @NeurosurgeryOSU | Neurosurgical Oncology, Immuno-oncology, Drug Delivery
ID: 391107847
https://pubmed.ncbi.nlm.nih.gov/?term=Damante+M# 15-10-2011 02:09:43
4,4K Tweet
465 Takipçi
851 Takip Edilen

Congratulations to Joshua H. Weinberg, MD, one of our PGY4 residents doing our clinical research track, on winning the Charles Kuntz IV Scholar Award at the 2025 AANS/CNS Spine Section annual meeting!








Thanks to Albert Isaacs, MD PhD FRCSC from Nationwide Children's Hospital for the great grand rounds talk on his work on the role of immune checkpoints on neonatal intraventricular hemorrhage.




A milestone in our fight against cancer: today, the 1st patient received the anti-#GARP CAR-T therapy for #GBM. Immense gratitude to this courageous patient and to the incredible team whose dedication made it possible. Pelotonia Institute for Immuno-Oncology The James Ohio State Neurosurgery Residency The Ohio State University Wexner Medical Center


#PIIO-1 (Anti-#GARP #CAR_T) is a milestone worth celebrating together. Grateful to the courageous patient and to everyone who made this possible. Here’s to changing lives. Zihai Li, MD, PhD Li Lab, #OSUCCC #CELL_THERAPY_LAB #Gratitude



Kreatsoulas et al. Ohio State Neurosurgery Residency Russell Lonser, M.D. developed and validated the MBLS to predict 90-day post-op survival in brain metastasis, offering a practical tool for pre-op risk stratification based on imaging and clinical factors. #JNO Read more:link.springer.com/article/10.100…


#NEUVisualAbstract Early Repeat Residual Resection Versus Adjuvant Therapy for Incompletely Resected Glioblastoma: A Case-Control Study bit.ly/4m7cseH by Mark Damante, MD et al The Ohio State University College of Medicine


